BTRX-335140
CAS No. 2244614-14-8
BTRX-335140( CYM-53093 )
Catalog No. M24021 CAS No. 2244614-14-8
BTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 282 | In Stock |
|
| 2MG | 149 | In Stock |
|
| 5MG | 250 | In Stock |
|
| 10MG | 407 | In Stock |
|
| 25MG | 841 | In Stock |
|
| 50MG | 1349 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBTRX-335140
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.
-
DescriptionBTRX-335140 is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) . BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats.
-
In VitroNavacaprant (BTRX-335140) (0-10 μM; 4 h) shows selective antagonist activity towards Kappa Opioid Receptor. Cell Viability Assay Cell Line:OPRK1-BLA U2OS cells Concentration:0-10 μM Incubation Time:4 hours Result:Exibited antagonist activity to KOR, DOR and MOR with IC50 values of 0.8, 110 and 6500 nM respectively, and showed selective antagonist activity to KOR.
-
In VivoNavacaprant (BTRX-335140) (0.01-3 mg/kg; p.o. once) reduces U69,593- stimulated plasma prolactin secretion to levels of without U69,593 treatment.Navacaprant (BTRX-335140) (1 mg/kg; i.p. once) blocks U-50488-induced antinociception from hot water.Animal Model:Rat PRL model Dosage:0.01, 0.03, 0.1, 0.3, 1 and 3 mg/kg Administration:Oral gavage; 0.01-3 mg/kg onceResult:Effectively decreased the high level prolactin caused by U69,593 even at a dosage of 0.1 mg/kg.Animal Model:Adult male ICR mice with tail dipped into 50°C hot water Dosage:1 mg/kg Administration:Intraperitoneal injection; 1 mg/kg once Result:Blocked the U-50488-induced antinociception at 1 h but not at 24 h pretreatment time and showed a medication-like duration of action in blocking the KOR.
-
SynonymsCYM-53093
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptorδ-opioid receptor|κ-opioid receptor|μ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2244614-14-8
-
Formula Weight453.55
-
Molecular FormulaC25H32FN5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:16.67 mg/mL (36.75 mM; Need ultrasonic)
-
SMILESCCc1cc2c(C)c(-c3nc(C)no3)c(N(CC3)CCC3NC3CCOCC3)nc2c(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guerrero M, et al. Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140). J Med Chem. 2019 Feb 28;62(4):1761-1780.
molnova catalog
related products
-
DuP 747 HCl
DuP 747 HCl is a selective kappa agonist with analgesic activity.DuP 747 consists of two conformations.
-
Calenduloside E
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
Spiradoline
Spiradoline (U 62066) is a potent, highly selective κ-opioid agonist that has analgesic diuretic and antitussive effects.
Cart
sales@molnova.com